Orienting network dysfunction in progressive multiple sclerosis (ID 208) Chalah MA 1,2, Palm U 1,3, Nguyen R 1,4, Créange A 1,4, Lefaucheur JP 1,2, Ayache.

Slides:



Advertisements
Similar presentations
Patient Cognitive Reserve and MS-Related Cognitive Dysfunction
Advertisements

Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.
Speed of processing, the missing measure in early detection of MCI? Ruth O’Hara March 13 th 2001 Yogesh Shah.
Real maximum walking speed on short distance assessed by a corrected version of the Timed 25 Foot Walk Test (T25FW) R. Phan Ba 1, 2, P. Calay 1, 2, P.
Examining the Relationship Between Confrontational Naming Tasks & Discourse Production in Aphasia Leila D. Luna & Gerasimos Fergadiotis Portland State.
Aim 2: Organizational Approach  PD patients demonstrated greater disorganization in copy trial approach than controls; t(2.09), p
The Unexplained Physical Symptom Robert K. Schneider, MD Assistant Professor Departments of Psychiatry, Internal Medicine and Family Practice Virginia.
© 2014 Direct One Communications, Inc. All rights reserved. 1 The Current Clinical Arena of Progressive Multiple Sclerosis Carrie M. Hersh, DO Mellen Center.
Tony WAEGEMANS, MD UCB Pharma, Belgium. TW/ll/ Washington/MCI 2 MCI as implemented in our study MCI is a very early stage of dementia with as main.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Defining the Clinical Course of Multiple Sclerosis.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Chair Timothy L. Vollmer, MD Professor of Neurology
Screening for Stroke and Cognitive Impairment Chapter 5: When is Cognitive Screening Limited?
Introduction Multiple Sclerosis (MS) is a chronic inflammatory disease characterized by the demyelization of axons within the central nervous system (CNS).
RESPONSE TO ANTIDEPRESSANT MEDICATION, COGNITIVE BEHAVIOR THERAPY AND PLACEBO IN CHRONIC TENSION-TYPE HEADACHE VARIES WITH PSYCHIATRIC COMORBIDITY & HEADACHE.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Sleep in the Pediatric Practice M. Mohammadi MD Professor of Pediatrics & Neurology Children’s Medical Center Hospital October 2005.
Specific Aim 1: Determine the impact of psychiatric disorders on the hospital length of stay (LOS) in pediatric patients diagnosed with SCD admitted for.
Effect of hydrotherapy in the rehabilitative treatment of Multiple Sclerosis (MS) Volanti P, Scialabba G, De Cicco D. Neurorehabilitation Unit Fondazione.
The Effect of Cognitive Fatigue on Language in Multiple Sclerosis Leena Maria Heikkola, Päivi Hämäläinen and Juhani Ruutiainen Åbo Akademi University,
The psychological and social sequela of HIV/AIDS infection are devastating to youth and their families. Individuals living with HIV/AIDS must cope with.
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
Control of Attention in schizophrenia 1.Advance understanding of schizophrenia. Move from description of deficits to explanation of specific mechanisms.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
INTRODUCTION Previous literature suggests that schizophrenia is characterized by a disturbed, fragmented and/or poorly elaborated personal identity (e.g.,
METHOD METHOD Long-Term Neuropsychological Functioning Following Mild Traumatic Brain Injury Nathalie C. Bérard and Dennis P. Alfano CONCLUSIONS The group.
INTRODUCTION RESULTS METHODS CONCLUSIONS Research partially supported by CONICET, CONICYT/FONDECYT.
Conversion Disorder (The Modern Hysteria)*
Attentional mechanisms of borderline personality disorder Posner et al. (2002)
Clinico-Radiological Profile of Spinal Cord Multiple Sclerosis Glenn H. Roberson Bhavik N. Patel Asim K. Bag University of Alabama at Birmingham, Birmingham,
NON PHARMACOLOGICAL THERAPY OF MENTAL IMAGERY AND RELAXATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT Poptsi Ε.,1,3, Κounti F.,1,3,Τsolaki, Μ. 1,2 1.
Cardiovascular disease in persons with anxiety or depressive disorders Nicole Vogelzangs 1,2, Adrie Seldenrijk 1,2, Aartjan TF Beekman 1,2, Hein PJ van.
Mental practice in chronic stroke- results of a randomized, placebo- controlled trial.
Journal Club Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy. Rebecca Luke 2/9/2016.
DIABETES AS A RISK FACTOR FOR COGNITIVE DECLINE IN OLDER PATIENTS F. Limongi, A. Marseglia, S. Maggi, M. Noale, G. Romanato, P. Siviero, G. Crepaldi CNR,
Association of Cognitive Outcomes and Response Status in Late Life Depression: A 12 Month Longitudinal Study David Bickford B.A., Alana Kivowitz B.A.,
The CRİTERİON-RELATED VALIDITY of the TURKISH VINELAND – II on CLINICAL GROUPS (Autism, Pervasive Developmental Disorder Not Otherwise Specified - PDD.
Health Related Quality of Life after serious occupational injuries and long term disability Presenter: Ibishi Nazmie MD,PhD University Clinical Center.
Objective Background Results Conclusions Research supported by The Lourie Center, Inc. The remotely supervised methods proved to be an effective and well-tolerated.
The Malfunctioning Mind: Degenerative Diseases of the Brain
The Effects of Physical Exercise on the Executive Functions of Children with Attention Deficit Hyperactivity Disorder: An Integrative Review of Literature.
Considering depression characteristics and antidepressants in the inflammation-depression relationship Nicole Vogelzangs Department of Psychiatry /
Cognitive Changes in Myotonic Dystrophy
Mobile Cognitive Training for Young Adults with Depressive Symptoms
Telehealth Mindfulness Meditation Improves
How Neurological Disability Influences the Quality of Life in People With Multiple Sclerosis Luísa Pedro / José Luís Pais Ribeiro Escola Superior de Tecnologia.
Table 1. Summary of Study Measures
Associate Director, Biostatistics
Brief Computerized Measures of Information Processing Speed are Sensitive to Multiple Sclerosis across the Lifespan M. Shaw1, C. Schwarz1, L.B. Krupp1,
CORRELATION OF BIOMARKERS FOR AXONAL DEGENERATION WITH RETINAL NERVE FIBER LAYER THICKNESS AND DISABILITY IN DIFFERENT PHASES OF MULTIPLE SCLEROSIS UZUNKOPRU.
Cognitive Biomarker of MS
Navigated rTMS for Pain Therapy - A Practical View for Clinical Application Moussa A. Chalah, Samar S. Ayache, Alaa Mhalla, Jean-Pascal Lefaucheur Clinical.
Averroes Prize Dr M. Abou Elew (Egypt).
Figure 2. Change in saccade frequency (without vs with a visual cue)
University of South Alabama Neurobehavioural Associates
Irma Höijer, M.Sc., Doctoral Student
Insert Footer or Copyright Information Here
Neuro-psychological Tests
Nat. Rev. Neurol. doi: /nrneurol
Rhematoid Rthritis Respiratory disorders
Figure 3 Archetypal MS clinical course depicted over 20 years
Alexa Stuifbergen, PhD, RN, FAAN Heather Becker, PhD, Frank Perez, PhD
Nat. Rev. Neurol. doi: /nrneurol
The Cedar Foundation.
Figure 1 Patterns of study retention The proportion of individuals actively participating in the study is displayed over the course of the study. Patterns.
Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis The rate.
Presentation transcript:

Orienting network dysfunction in progressive multiple sclerosis (ID 208) Chalah MA 1,2, Palm U 1,3, Nguyen R 1,4, Créange A 1,4, Lefaucheur JP 1,2, Ayache SS 1,2 1 EA 4391, Excitabilité Nerveuse et Thérapeutique, Université Paris-Est-Créteil, France 2 Service de Physiologie – Explorations Fonctionnelles, Hôpital Henri Mondor, Assistance Publique – Hôpitaux de Paris, Créteil, France 3 Department of Psychiatry, Psychotherapy and Psychosomatics, Ludwig-Maximilian University, Germany 4 Service de Neurologie, Hôpital Henri Mondor, Assistance Publique – Hôpitaux de Paris, Créteil, France Background / Objective  Cognitive impairment affects up to 70 % of multiple sclerosis (MS) patients; the most frequently impaired domains being memory, processing speed and attention. In progressive MS subtypes, the increase in lesion load and cerebral atrophy throughout disease progression might have more impact on the attentional capacities.  The Attention Network Test (ANT) is a validated tool to assess the three main attentional networks: alerting network that controls vigilance, orienting network in charge of orientation to external stimuli, and executive function network that deals with solving conflict.  Our objective was to assess the attentional networks in progressive MS using ANT (figures 1 and 2). Methods  25 patients with primary (n = 10) or secondary (n=15) progressive MS and 25 age and sex matched healthy subjects were enrolled. All participants were right-handed. For the patients group, the following inclusion criteria were used: (i) definite diagnosis of progressive MS according to the revised 2010 McDonald criteria, (ii) stable treatment since at least one month, (iii) absence of comorbid neurologic or psychiatric disorders, particularly depression defined as Beck Depression Inventory score >19, (iv) absence of severe upper limb impairment and (v) absence of visual acuity or field deficits.  The cognitive screening and attention evaluation were performed in all participants using the Symbol Digit Modality Test (SDMT) and ANT respectively.. Results  Regarding ANT parameters, MS patients were slower and less accurate than their healthy counterparts; and were found to have a significative deficit in the orienting network.  ANT parameters were positively correlated with the disability scores and the progressive phase duration.  Concerning SDMT, MS patients scored less than the healthy subjects Vázquez-Marrufo, M. et al., Neural correlates of alerting and orienting impairment in multiple sclerosis patients. PLoS One. 12;9:e Fan, J.et al., Testing the efficiency and independence of attentional networks. J. Cogn. Neurosci.14, References Figure 2 Conclusion  Our study was the first to report an exclusive dysfunction in the orienting network of attention in progressive MS; such a finding might be attributed to the higher number of cortical lesions reported in progressive MS compared to the relapsing remitting forms.  Our study further supports the value of ANT and SMDT in evaluating different aspects of cognitive impairment in MS patients, and emphasizes the alteration of the orienting attentional network in MS patients with progressive subtypes. Figure 1